Screening of JAK 2 V617F and MPL W515 K/L negative essential thrombocythaemia patients for mutations in SESN 2, DNAJC 17, ST 13, TOP 1 MT , and NTRK 1-Reference-Cited by-同舟云学术

Screening of JAK 2 V617F and MPL W515 K/L negative essential thrombocythaemia patients for mutations in SESN 2, DNAJC 17, ST 13, TOP 1 MT , and NTRK 1

Published:2014-02-26 Issue:5 Volume:165 Page:734-737
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

AL Assaf Carla¹,Lierman Els¹,Devos Timothy²,Billiet Johan³,Graux Carlos⁴,Papadopoulos Petros¹,Vandenberghe Peter¹

Affiliation:

1. Centre for Human Genetics KU Leuven and University Hospital Leuven LeuvenBelgium

2. Department of Haematology University Hospital Leuven Leuven Belgium

3. Laboratory of Haematology AZ Sint‐Jan BruggeBelgium

4. Department of Haematology Mont‐Godinne University Hospital YvoirBelgium

Funder

FP7

KU Leuven

Research Foundation-Flanders

Stichting tegen Kanker

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.12790

Reference10 articles.

1. A method and server for predicting damaging missense mutations

2. Single-Cell Exome Sequencing and Monoclonal Evolution of a JAK2-Negative Myeloproliferative Neoplasm

3. JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science

4. Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

5. A Gain-of-Function Mutation ofJAK2in Myeloproliferative Disorders

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inclusion of Hsp70 co-chaperone and RNA binding activities facilitate optimal function of spliceosomal disassembly factor Cwf23 in intron-richSchizosaccharomyces pombe;2024-06-27

2. Aflibercept Intervention in Experimental Branch Retinal Vein Occlusion Results in Upregulation of DnaJ Homolog Subfamily C Member 17;Journal of Ophthalmology;2021-03-06

3. DNAJC17 is localized in nuclear speckles and interacts with splicing machinery components;Scientific Reports;2018-05-17

4. Chronic myeloproliferative neoplasms;Cancer Cytogenetics;2015-06-26